• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Genome Sequencing Identifies Genetic Factors in Unexplained Recurrent Miscarriages

by
November 21, 2026
in Health
Reading Time: 6 mins read
0
Genome Sequencing Identifies Genetic Factors in Unexplained Recurrent Miscarriages

Genome Sequencing Identifies Genetic Factors in Unexplained Recurrent Miscarriages

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A multicenter study led by researchers at Stanford Medicine and collaborating institutions has uncovered potential genetic explanations in thirty out of 118 families who experienced repeated, unexplained pregnancy losses. Published on November 16, 2026, in the peer-reviewed journal Genome Medicine, the investigation focused specifically on cases where embryos or fetuses possessed a normal number of chromosomes and showed no structural abnormalities during routine ultrasound examinations. By performing comprehensive whole-genome sequencing on both parents as well as tissue from the miscarried pregnancies, the scientific team detected functional gene alterations that shed light on biological mechanisms responsible for early developmental failure.

Recurrent pregnancy loss is clinically defined as the occurrence of two or more miscarriages and impacts an estimated five percent of couples trying to establish a family. In roughly seventy percent of these cases, standard diagnostic assessments show that the miscarried fetuses are chromosomally normal, or euploid, leaving clinicians without a clear cause. For prospective parents, this absence of medical explanation often leads to years of uncertainty and grief, as conventional diagnostic evaluations typically conclude without identifying why the losses continue to happen.

Historically, investigating the underlying causes of recurrent chromosomally normal miscarriages has been constrained by small sample sizes and narrow sequencing approaches. Prior published studies collectively analyzed only approximately sixty miscarried pregnancy samples, frequently evaluating merely four to eight families at a time. Furthermore, earlier genetic investigations predominantly sequenced DNA isolated solely from the miscarried pregnancies. That isolated approach made it exceptionally difficult to determine whether detected genetic variants were inherited from healthy parents or arose spontaneously in the embryo, confounding efforts to distinguish harmless background variation from genuinely damaging mutations.

To overcome these limitations, the research team, operating across five academic centers, initially enrolled 176 families between 2022 and 2024. The study protocol incorporated strict quality control criteria: researchers excluded samples exhibiting large-scale chromosomal anomalies as well as those containing poor-quality DNA that could not yield dependable sequence data. Following these exclusions, a cohort of 118 families remained in the final analytical group. Within this cohort, approximately 79 percent of the pregnancy losses occurred during the first trimester, and 95 percent of the gestations demonstrated entirely normal anatomy without structural birth defects on prenatal ultrasound imaging.

Because comprehensive genome sequencing routinely identifies hundreds of potentially relevant variations in every family, the investigators established a systematic filtering strategy to pinpoint candidate mutations. The team prioritized genes already documented in scientific literature to cause lethal conditions in newborn infants or stillborn babies, as well as genes linked to prenatal lethality in mouse models. The researchers then cross-referenced these candidate genes against published expression databases to confirm whether each gene is normally active in the human embryo or fetus at the exact gestational stage corresponding to when the specific pregnancy loss occurred.

Through this prioritized analysis, the team identified functional genetic alterations in thirty families, representing 25.4 percent of the cohort. In 18 families, or 15.3 percent of the total group, researchers detected pathogenic or likely pathogenic variants in genes directly governing early human embryonic development. In an additional 12 families, accounting for 10.2 percent of the cohort, the sequencing uncovered variants of uncertain significance. These variants of uncertain significance represent suggestive molecular alterations where current scientific evidence is not yet definitive enough to prove an established cause of miscarriage.

The study demonstrated that the vast majority of identified variants were inherited rather than arising de novo in the developing embryo. In 24 of the 30 families with identified genetic alterations, at least one parent carried the variant despite experiencing no clinical symptoms themselves. Because an unaffected carrier parent can transmit the identical damaged genetic variant across multiple consecutive pregnancies, this inheritance pattern provides a plausible biological mechanism explaining why pregnancy losses repeatedly recur within the same family.

Multiple distinct inheritance patterns emerged from the sequencing data across the cohort. The most prevalent pattern, identified in 11 families, involved autosomal recessive damage affecting both functional copies of a single gene. While a parent carrying only one altered copy remains healthy due to the presence of a functioning backup copy, an embryo that inherits an abnormal copy from each parent suffers total loss of that gene’s critical developmental activity. For instance, in one family, both parents carried a damaged copy of DHCR7, a gene essential for regulating cholesterol biosynthesis. While two defective copies of DHCR7 cause Smith-Lemli-Opitz syndrome in live-born infants, the syndrome occurs far less often at birth than population carrier frequencies would predict. The family’s 12-week loss provides direct molecular evidence supporting the hypothesis that this discrepancy is driven by early embryonic death.

Other families displayed alternative genetic mechanisms, including X-linked and mosaic inheritance. In five families, male embryos inherited a damaging variation located on the single maternal X chromosome; lacking a second compensating X chromosome, these male embryos had no functional backup copy to sustain normal development. In two other families, testing revealed parental mosaicism, a condition in which a parent carries a genetic variant in only a subpopulation of their cells, including their germline reproductive cells such as sperm or eggs. In several additional families, a single damaged gene copy inherited from an unaffected or mildly affected parent appeared sufficient to cause pregnancy loss, suggesting heightened embryonic vulnerability or compounding developmental stressors.

Across the cohort, the investigators cataloged variants spanning 28 distinct genes, of which 13 had previous clinical links to stillbirth or newborn death, while 15 had never before been reported in connection with pregnancy loss. The biological timing of gene expression closely mirrored the developmental age at which losses took place. For example, a mutation in HNRNPK, a gene that processes genetic messages across the early embryo, was identified in an eight-week miscarriage, whereas a mutation in PRF1, a component of the immune system’s cell-killing machinery active in later gestation, was discovered in a pregnancy lost at 28 weeks.

The findings also illustrated the complexity of recurrent loss, as not every miscarriage within a family shared the same variant. In three families—two carrying variants in FGFR2, which coordinates embryonic patterning, and one carrying a variant in MAGED2, which regulates fetal fluid homeostasis—tissue samples from additional miscarriages lacked the family’s candidate variant, indicating that different underlying factors caused those particular losses. Furthermore, in four families, representing 3.4 percent of the cohort, damage was detected across both copies of seven genes with no prior association with human disease, though existing evidence remained too limited to classify them as more than uncertain.

The researchers emphasize that while sequencing parental and fetal genomes could one day supplement standard chromosomal screening and assist in reproductive risk assessment, variants of uncertain significance and newly implicated genes must not be used to guide embryo selection or clinical decisions until broader validation is achieved. Ongoing research by the collaborative team is actively enrolling additional families to rigorously verify which candidate genes definitively cause developmental arrest, laying the scientific groundwork for prospective preconception carrier screening that could one day identify reproductive risks before pregnancy occurs.

Beyond the genetic data, the research team highlighted the profound personal toll experienced by couples facing repeated pregnancy loss without an identifiable cause. Ruth Lathi, MD, professor of obstetrics and gynecology at Stanford Medicine and medical director of the Recurrent Pregnancy Loss program, emphasized that recurrent pregnancy loss is far more than a routine diagnosis, carrying lasting grief for prospective parents and their families. Because recurrent loss is poorly understood and frequently left unexplained, discovering definitive biological mechanisms represents an essential milestone toward mitigating future losses and assisting patients in achieving successful pregnancies. Svetlana Yatsenko, MD, professor of pathology at Stanford Medicine, observed that multiple participating couples had endured ten or more miscarriages, and several remained without living children after being repeatedly assured that their reproductive failures were merely the result of bad luck.

A primary obstacle in resolving these unexplained cases stems from the absence of visible physical clues during the earliest stages of gestation. While damaged genes known to cause lethal conditions in newborns often present with noticeable anomalies, first-trimester miscarriages typically exhibit no visible birth defects or structural phenotypes that could guide clinicians toward a specific genetic target. To overcome this diagnostic barrier, the authors propose adapting clinical frameworks from existing medical genetics. Yatsenko noted that the approach mirrors standard preconception carrier screening, where prospective parents are routinely evaluated for variants linked to severe childhood disorders. In this context, screening would evaluate the risk of miscarriage itself, opening possibilities for preventive interventions before conception occurs. For couples identified with established pathogenic variants, clinicians could potentially utilize in vitro fertilization coupled with genetic testing of embryos prior to transfer, offering a targeted strategy to lower recurrence risk.

The investigation reflects a collaborative effort across multiple academic medical centers and specialized diagnostic partners. Yatsenko shares senior authorship of the publication with Lathi and Aleksandar Rajkovic, MD, PhD, professor of pathology and of obstetrics, gynecology and reproductive sciences at the University of California, San Francisco. Mona Aminbeidokhti, PhD, a postdoctoral fellow at UCSF, served as the study’s lead author. Additional contributions were provided by researchers from Oregon Health & Science University, the University of Illinois Chicago, and Natera. Supported by grant R01 HD105256 from the National Institutes of Health, the research establishes a starting point for families who historically lacked explanatory answers, providing a scientific foundation to expand diagnostic sequencing and clarify the genetic architecture of early developmental arrest.

Subject of Research: Identification of genetic variants underlying recurrent chromosomally normal pregnancy loss through parental and fetal genome sequencing

Article Title: Clues to unexplained recurrent miscarriage found via genome sequencing

Article References: Clues to unexplained recurrent miscarriage found via genome sequencing. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Recurrent pregnancy loss, Genome sequencing, Euploid miscarriage, Genome Medicine, Stanford Medicine, Svetlana Yatsenko, Ruth Lathi, Aleksandar Rajkovic, Pathogenic variants, Variants of uncertain significance, DHCR7, Smith-Lemli-Opitz syndrome, FGFR2, MAGED2, HNRNPK, PRF1, Genetic mosaicism, Preconception carrier screening

News Source: Juliet Wilcox. (November 21, 2026). Genome Sequencing Identifies Genetic Factors in Unexplained Recurrent Miscarriages. Scienmag.

Tags: Aleksandar RajkovicDHCR7euploid miscarriageFGFR2genetic mosaicismGenome Medicinegenome sequencingHNRNPKMAGED2pathogenic variantsPreconception carrier screeningPRF1Recurrent Pregnancy LossRuth LathiSmith-Lemli-Opitz syndromeStanford MedicineSvetlana YatsenkoVariants of uncertain significance
Share12Tweet7Share2ShareShareShare1

Related Posts

Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

November 22, 2026
Rare Neural Autoantibodies Identified in Cerebrospinal Fluid in Schizophrenia Spectrum Disorders

Rare Neural Autoantibodies Identified in Cerebrospinal Fluid in Schizophrenia Spectrum Disorders

November 22, 2026

Pyrogallic Acid Restores Doxycycline Susceptibility in Multidrug-Resistant Enterotoxigenic Escherichia Coli

November 22, 2026

Adjunctive Phage Therapy Achieves Eighty-Two Percent Remission in Refractory Musculoskeletal Infections

November 22, 2026

POPULAR NEWS

  • LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

    LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

    29 shares
    Share 12 Tweet 7
  • Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

    29 shares
    Share 12 Tweet 7
  • Rare Neural Autoantibodies Identified in Cerebrospinal Fluid in Schizophrenia Spectrum Disorders

    29 shares
    Share 12 Tweet 7
  • Pyrogallic Acid Restores Doxycycline Susceptibility in Multidrug-Resistant Enterotoxigenic Escherichia Coli

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

Rare Neural Autoantibodies Identified in Cerebrospinal Fluid in Schizophrenia Spectrum Disorders

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.